/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

Y

Yuji Kumagai

Kitasato Institute Hospital(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

212

Papers

2.8K

Citations

27

h-index

72

i10-index

Yuji Kumagai is an academic researcher from Kitasato Institute Hospital. The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Cardiac electrophysiology and arrhythmias & Drug Transport and Resistance Mechanisms. The author has an h-index of 27, co-authored 181 publications.

Research Topics

Pharmacogenetics and Drug Metabolism Cardiac electrophysiology and arrhythmias Drug Transport and Resistance Mechanisms Coagulation, Bradykinin, Polyphosphates, and Angioedema Analytical Methods in Pharmaceuticals

Papers by this author

works

Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial

2023 · The Lancet Infectious Diseases · 105 citations

https://doi.org/10.1016/s1473-3099(23)00650-3

Yoshiaki Oda Yuji Kumagai Manabu Kanai Yasuhiro Iwama

Chronoastrobiology: proposal, nine conferences, heliogeomagnetics, transyears, near-weeks, near-decades, phylogenetic and ontogenetic memories

2004 · Biomedicine & Pharmacotherapy · 54 citations

https://doi.org/10.1016/s0753-3322(04)80025-8

Franz Halberg Germaine Cornélissen Philip J. Regal Kuniaki Otsuka

Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers

2012 · European Journal of Clinical Pharmacology · 22 citations

https://doi.org/10.1007/s00228-012-1373-8

Jun Tanaka Hidefumi Kasai Kenji Shimizu Shigeki Shimasaki

Association of multidrug resistance-associated protein 2 single nucleotide polymorphism rs12762549 with the basal plasma levels of phase II metabolites of isoflavonoids in healthy Japanese individuals

2012 · Pharmacogenetics and Genomics · 21 citations

https://doi.org/10.1097/fpc.0b013e3283517012

Koji Kato Hiroyuki Kusuhara Yuji Kumagai Ichiro Ieiri

Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial

2024 · The Lancet Infectious Diseases · 6 citations

https://doi.org/10.1016/s1473-3099(24)00565-6

Yusuke Okada Yuji Kumagai Iori Okura MASAO OTSUKI

Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects

2022 · Journal of Pharmacological Sciences · 3 citations

https://doi.org/10.1016/j.jphs.2022.08.007

Ryuichi Kambayashi Ai Goto Hiroko Izumi‐Nakaseko Ichiro Oikawa

Research topics

topics

Pharmacogenetics and Drug Metabolism

Cardiac electrophysiology and arrhythmias

Drug Transport and Resistance Mechanisms

Coagulation, Bradykinin, Polyphosphates, and Angioedema

Analytical Methods in Pharmaceuticals

Chat about Author

Papers

Chat

Click to start Chat